Sinclair IS Pharma Share Price (SPH)

27.50 0.00 (0.00%) delayed: 2:54AM BST
Bid price 0.00 Open price 27.75
Ask price 0.00 Prev close 27.50
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Sinclair IS Pharma share prices, Sinclair IS Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Sinclair IS Pharma Level 2 Data, indepth research tools and investor commentary for Sinclair IS Pharma (SPH) and other London Stock Exchange equities.

Sinclair IS Pharma Share Price Chart

Advanced Charts >>

Register now for FREE Sinclair IS Pharma share price charts

Sinclair IS Pharma Share Price Information

Name Sinclair IS Pharma Epic SPH
Sector Pharmaceuticals & Biotechnology ISIN GB0033856740
Activites Sinclair IS Pharma plc (formerly Sinclair Pharma plc) is a speciality pharma company providing solutions to treat dermatological diseases through advanced surface technology and innovative delivery systems. Index n/a

Sinclair IS Pharma Key Numbers

Latest Share Price (p) 27.50 Net Gearing (%) 58.58
Market Capitalisation (£m) 136.19 Gross Gearing (%) 63.01
Shares in issue (m) 497.41 Debt Ratio 55.77
P/E Ratio -18.25 Debt-to-Equity Ratio 0.74
Total dividends per share (p) 0.00 Assets / Equity Ratio 2.70
Dividend Yield (%) 0.00 Price to book value 1.29
Dividend cover (x) 0.00 ROCE (%) -3.41
Earning per share (p) -1.50 EPS Growth (%) -25.00
52 week high / low 41.50 / 26.38 DPS Growth (%) n/a

Sinclair IS Pharma Director Deals

Dec.Date Type Director Pos No. of Shares
31/05/2016 BUY Jean-Charles Tschudin NED 3,023
31/05/2016 BUY Jean-Charles Tschudin NED 97,000
23/05/2016 BUY Jean-Charles Tschudin NED 250,000
20/05/2016 BUY Christopher Spooner CEO 150,000
20/05/2016 BUY Christophe Foucher ED 31,500

More Sinclair IS Pharma Director Deals >>

Sinclair IS Pharma Company News

14:02 22/09/2016

Holding(s) in Company

/* */ RNS Number : 5913K Sinclair Pharma PLC 22 September 2016     For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN...

07:25 21/09/2016

Sinclair Pharma more than halves H1 pretax loss

Sinclair Pharma has more than halved its H1 pretax loss to £3.4m, from a loss of £7.2m. Revenue was marginally lower at £17.25m, from £17.29m. CEO Chris Spooner commented: "We have made material progress in our strategy of building a high growth, global pure-play...

07:15 21/09/2016

FLASH: Sinclair Pharma more than halves H1 pretax loss

Story provided by StockMarketWire.com

More Sinclair IS Pharma Company News >>

Register now for FREE Sinclair IS Pharma company news

Sinclair IS Pharma Share Price Discussions

more than 1 year ago

Bargain shares - but only for Directors! (SPH)

However, you read it, the News today that Dir have been given shares at 1p when the Market mid is 28p looks like something out of the book "They never told such a story, you dreamt it" So just what performance does such largess reward, I wonder? Ah yes, the sp has increased 10-fold, ah so....

more than 1 year ago

Take over bid rejected (SPH)

News article which appears to have gone unnoticed. From "THIS IS MONEY" website Ubiquitious Warburg Pincus has completed more initial public offerings (IPOs) than any other private equity firm. It is currently putting its considerable weight behind a proposed $1.5bn IPO of Bausch & Lomb,...

more than 1 year ago

Trading update due July (SPH)

Year end 30th June and a trading update out early July. A couple of Funds have been topping up in recent weeks. 62.5% of shares now with investment funds plus another 3.42% with directors.

Register now for FREE Sinclair IS Pharma share price discussions